AbbVie Inc. (ABBV) Income statement

Top 20 of 28 line items reported by ABBV · 250+ in the full API →

AbbVie Inc. (ABBV) · Income Statement

Consolidated Statements of Operations

Quarterly · In millions USD, except per-share data · Latest filed Nov 3, 2026 · FY ends Dec 31

Three Months Ended
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Trend
Total Revenue$17,404$16,990$15,002$16,618$15,776
Cost of Revenue4,2854,2914,2184,5525,304
Gross Profit$13,119$12,699$10,784$12,066$10,472
Other Operating Expenses6,8526,2676,7947,5228,568
Total Operating Expenses11,13710,55811,01212,07413,872
Operating Income$6,267$6,432$3,990$4,544$1,904
EBIT (Earnings Before Interest & Tax)6,2676,4323,9904,5441,904
Add: Depreciation & Amortization1,8921,8941,9361,9872,092
EBITDA (Non-GAAP)$8,159$8,326$5,926$6,531$3,996
Interest Income1026772(655)72
Interest Expense-802-746-717-714-739
Foreign Exchange Gain (Loss)———(11)(20)
Non-Operating Income (Expense)$(700)$(679)$(645)$(1,380)$(687)
Income Before Taxes (EBT)$4,829$4,278$1,039$2,668$714
Provision for Income Taxes609662342853526
Effective Tax Rate12.6%15.5%32.9%32%73.7%
Net Income$4,218$3,613$695$1,816$186
Shares Outstanding1,7691,7691,7701,7691,769
Diluted Earnings Per Share$2.37$2.03$0.39$1.02$0.10
Gross Margin75.4%74.7%71.9%72.6%66.4%
8 more line items available via the API
Research & DevelopmentSales, General & AdministrativeAsset Impairment ChargesDiluted Shares OutstandingBasic Earnings Per ShareOperating MarginOther OpEx MarginNet Margin
Ask your agent:get_financialsAPIGET /api/v1/companies/ABBV/income-statement?period=quarterly&years=2Docs →